Departamento académico
(FM) Inmunología
Publicacions (20) Publicacions en què ha participat algun/a investigador/a
2018
-
A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis
Journal for ImmunoTherapy of Cancer, Vol. 6, Núm. 1
-
A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
Nature Communications, Vol. 9, Núm. 1
-
An rna toolbox for cancer immunotherapy
Nature Reviews Drug Discovery, Vol. 17, Núm. 10, pp. 751-767
-
CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8+ T Cell-Relevant Genes
Cancer Immunology Research, Vol. 6, Núm. 1, pp. 69-78
-
CD137 (4-1BB) signalosome: Complexity is a matter of TRAFs
Frontiers in Immunology, Vol. 9, Núm. NOV
-
Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients
Annals of Oncology, Vol. 29, Núm. 5, pp. 1312-1319
-
Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB)
OncoImmunology, Vol. 7, Núm. 1
-
Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15
OncoImmunology, Vol. 7, Núm. 2
-
Epistatic oncogenic interactions determine cancer susceptibility to immunotherapy
Cancer Discovery, Vol. 8, Núm. 7, pp. 794-796
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483
-
ICAM-1-LFA-1 dependent CD8+ T-lymphocyte aggregation in tumor tissue prevents recirculation to draining lymph nodes
Frontiers in Immunology, Vol. 9, Núm. SEP
-
Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect
Trends in Immunology, Vol. 39, Núm. 8, pp. 644-655
-
Immunotherapy of hepatocellular carcinoma: Facts and hopes
Clinical Cancer Research, Vol. 24, Núm. 7, pp. 1518-1524
-
Immunotherapy targeting 4-1BB: Mechanistic rationale, clinical results, and future strategies
Blood, Vol. 131, Núm. 1, pp. 49-57
-
Mitochondrial morphological and functional reprogramming following CD137 (4-1BB) Costimulation
Cancer Immunology Research, Vol. 6, Núm. 7, pp. 798-811
-
Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)
Blood cancer journal, Vol. 8, Núm. 12, pp. 117
-
Perspectives in immunotherapy: Meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)
Journal for ImmunoTherapy of Cancer, Vol. 6, Núm. 1
-
Radiation effects on antitumor immune responses: Current perspectives and challenges
Therapeutic Advances in Medical Oncology, Vol. 10
-
Revisiting interleukin-12 as a cancer immunotherapy agent
Clinical Cancer Research, Vol. 24, Núm. 12, pp. 2716-2718
-
Starting the fight in the tumor: Expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)
Annals of Oncology, Vol. 29, Núm. 11, pp. 2163-2174